Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells

被引:79
作者
Chen, Xin
Howard, O. M. Zack
Oppenheim, Joost J.
机构
[1] NCI, Basic Res Program, SAIC Frederick Inc, Mol Immunoregulat Lab, Frederick, MD 21702 USA
[2] NCI, Mol Immunoregulat Lab, Ctr Canc Res, Frederick, MD 21702 USA
关键词
D O I
10.4049/jimmunol.178.10.6123
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Compelling evidence has now demonstrated that IL-17-producing CD4 cells (Th17) are a major contributor to autoimmune pathogenesis, whereas CD4(+)CD25(+) T regulatory cells (Treg) play a major role in suppression of autoimmunity. Differentiation of proinflammatory Th17 and immunosuppressive Treg from naive CD4 cells is reciprocally related and contingent upon the cytokine environment. We and others have reported that in vivo administration of pertussis toxin (PTx) reduces the number and function of mouse Treg. In this study, we have shown that supernatants from PTx-treated mouse splenic cells, which contained IL-6 and other proinflammatory cytokines, but not PTx itself, overcame the inhibition of proliferation seen in cocultures of Treg and CD4(+)CD25(-) T effector cells. This stimulatory effect could be mimicked by individual inflammatory cytokines such as IL-1 beta, IL-6, and TNF-a. The combination of these cytokines synergistically stimulated the proliferation of CD4+CD25- T effector cells despite the presence of Treg with a concomitant reduction in the percentage of FoxP3(+) cells and generation of IL-17-expressing cells. PTx generated Th17 cells, while inhibiting the differentiation of FoxP(+) cells, from naive CD4 cells when cocultured with bone marrow-derived dendritic cells from wild-type mice, but not from IL-6(-/-) mice. In vivo treatment with PTx induced IL-17-secreting cells in wild-type mice, but not in IL-6(-/-) mice. Thus, in addition to inhibiting the development of Treg, the immunoadjuvant activity of PTx can be attributable to the generation of IL-6-dependent IL-17-producing CD4 cells. The Journal of Immunology, 2007, 178: 6123-6129.
引用
收藏
页码:6123 / 6129
页数:7
相关论文
共 48 条
  • [1] Native and genetically inactivated pertussis toxins induce human dendritic cell maturation and synergize with lipopolysaccharide in promoting T helper type 1 responses
    Ausiello, CM
    Fedele, G
    Urbani, F
    Lande, R
    Di Carlo, B
    Cassone, A
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (03) : 351 - 360
  • [2] Multiple sclerosis and infectious childhood diseases
    Bachmann, S
    Kesselring, J
    [J]. NEUROEPIDEMIOLOGY, 1998, 17 (03) : 154 - 160
  • [3] Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
    Bettelli, E
    Carrier, YJ
    Gao, WD
    Korn, T
    Strom, TB
    Oukka, M
    Weiner, HL
    Kuchroo, VK
    [J]. NATURE, 2006, 441 (7090) : 235 - 238
  • [4] Brabb T, 1997, J IMMUNOL, V159, P497
  • [5] BURNETTE WN, 1997, BEHRING I MITT, V98, P434
  • [6] Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells
    Cassan, Cecile
    Piaggio, Eliane
    Zappulla, Jacques P.
    Mars, Lennart T.
    Couturier, Nicolas
    Bucciarelli, Florence
    Desbois, Sabine
    Bauer, Jan
    Gonzalez-Dunia, Daniel
    Liblau, Roland S.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 177 (03) : 1552 - 1560
  • [7] Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells
    Chen, X
    Winkler-Pickett, RT
    Carbonetti, NH
    Ortaldo, JR
    Oppenheim, JJ
    Howard, OMZ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (03) : 671 - 680
  • [8] Glucocorticoid amplifies IL-2-dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE
    Chen, Xin
    Oppenheim, Joost J.
    Winkler-Pickett, Robin T.
    Ortaldo, John R.
    Howard, O. M. Zack
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (08) : 2139 - 2149
  • [9] Infections and autoimmunity - Good or bad?
    Christen, U
    von Herrath, MG
    [J]. JOURNAL OF IMMUNOLOGY, 2005, 174 (12) : 7481 - 7486
  • [10] Curtsinger JM, 1999, J IMMUNOL, V162, P3256